| CI | Confidence interval |
| DPC4 | Deleted in pancreatic cancer 4 |
| FFPE | Formalin fixed paraffin embedded |
| FOLFIRINOX | 5-FU, folinic acid, irinotecan, oxaliplatin |
| HR | Hazard ratio |
| IHC | Immunohistochemistry |
| KPS | Karnofsky performance status |
| LAPC | Locally advanced pancreatic cancer |
| µm | Micrometer |
| nab-paclitaxel | Nanoparticle albumin-bound paclitaxel |
| OS | Overall survival |
| PC | Pancreatic cancer |
| PFS | Progression-free survival |
| pts | patients |
| RUNX3 | Runt-related transcription factor 3 |
| SMAD4 | Mothers against decapentaplegic homolog 4 |
| US | United States |